References
1. Beauchemin C, et al. Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis- A Canadian Cost-Utility Analysis. 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PIN44, 16 Nov 2020. Available from: URL: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2020-3282/105938
2. Ines M, et al. The Cost-Effectiveness of Isavuconazole in the Treatment of Invasive Fungal Infections in Portugal. 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PDG24, 16 Nov 2020. Available from: URL: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2020-3282/108491
Rights and permissions
About this article
Cite this article
Isavuconazole cost effective for invasive fungal infections. PharmacoEcon Outcomes News 868, 24 (2020). https://doi.org/10.1007/s40274-020-7356-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7356-6